zilucoplan

Watch out, AstraZeneca: UCB uncorks late-stage success for $2.1B Soliris rival
Endpoints
Fri, 02/4/22 - 11:11 am
UCB Pharma
clinical trials
myasthenia gravis
AstraZeneca
Soliris
zilucoplan
UCB strikes $2.5B deal to buy Ra for rival to Alexion's Soliris
Fierce Biotech
Thu, 10/10/19 - 12:56 pm
UCB Pharma
Ra Pharmaceuticals
M&A
zilucoplan
Alexion
Soliris
Ra Pharma files $100M round as Soliris rival clears phase 2 trial
Fierce Biotech
Tue, 12/11/18 - 11:49 am
Ra Pharma
Soliris
clinical trials
myasthenia gravis
zilucoplan